• Search
  • Featured ▾
  • Following
  • Upload
  • Account
  • Search

    • Assessing and addressing biopharmaceutical aggregation

    Posted by

    LabTube Meets

    1,002 views

    |

    October 26, 2018

  • Share
  • Add to Playlist
  • Bookmark

    • Dr David Brockwell, University of Leeds, explains aggregation and why protein-based pharmaceuticals are particularly susceptible to it.

    Drug Discovery
    Up Next
    Autoplay
    video
    Play Video
    01:42
    Targeting the Src N-Terminal Regulatory Element in Cancer
    Oncotarget
    11 months ago
    Cancer ResearchCell ScienceDrug Discovery
    video
    Play Video
    00:27
    Groundbreaking trace elemental analysis Thermo Scientific iCAP™ Q ICPMS
    Chromatography & Mass Spectrometry Solutions
    12 years ago
    Analytical TechniquesChromatographyDrug DiscoveryFlow Chemistry
    video
    Play Video
    38:42
    Harnessing Synthetic Biology for Fine and Speciality Chemical Production
    RebelBio
    8 years ago
    Drug DiscoveryGenomics
    More Videos from LabTube Meets
    video
    Play Video
    07:59
    Drug Discovery Digitial 2020
    LabTube Meets
    4 years ago
    Drug Discovery
    video
    Play Video
    06:40
    LabTube Meets JEOL USA, Benjamin Muller
    LabTube Meets
    4 years ago
    Analytical TechniquesImaging/Microscopy
    video
    Play Video
    03:02
    LabTube Meets SCIEX, Oscar G. Cabrices
    LabTube Meets
    4 years ago
    Analytical TechniquesMass Spectrometry
    Playlists featuring LabTube Meets
    15
    playlist
    Play All
    LabTube Meets at Pittcon 2020
    LabTube Meets
    27
    playlist
    Play All
    LabTube Meets at SLAS 2020
    LabTube Meets
    13
    video
    Play All
    ELRIG Drug Discovery 2019
    LabTube Meets

    Keep up to date with all your favourite videos and channels.

    Get personalised notifications on new releases and channel content by subscribing to the LabTube eNewsletter.